This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
Food and Drug Administration, HHS.
Final rule; correcting amendments.
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect revised human food safety warnings or updated pathogen nomenclature on dosage form new animal drug product labeling that have not been codified. The regulations are also being amended to correct the wording of certain other conditions of use, to correct minor errors, and to revise some sections to reflect a current format. These actions are being taken to comply with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and to improve the accuracy and readability of the regulations.
This rule is effective March 29, 2011.
George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, e-mail: george.haibel@fda.hhs.gov.
FDA has found that the animal drug regulations do not reflect certain human food safety warnings or the scientific nomenclature of pathogens that have been updated on labeling of various dosage form new animal drug products. At this time, the regulations are being amended to reflect approved labeling. The regulations are also being amended to correct the wording of certain other conditions of use and to correct minor errors. As the opportunity has presented itself, some sections have been revised to a current format. These actions are being taken to comply with the FD&C Act and to improve the accuracy and readability of the regulations.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Animal drugs.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 520, 522, 526, and 529 are amended as follows:
1. The authority citation for 21 CFR part 520 continues to read as follows:
2. In § 520.550, revise the section heading and paragraph (a), the first sentence in paragraph (c)(1), and paragraph (c)(3) to read as follows:
(a) Specifications. The product is distributed in packets each of which contains the following ingredients: Sodium chloride 8.82 grams, potassium phosphate 4.20 grams, citric acid anhydrous 0.5 gram, potassium citrate 0.12 gram, aminoacetic acid (glycine) 6.36 grams, and glucose 44.0 grams.
(c) * * *
(1) Glucose/glycine/electrolyte is indicated for use in the control of dehydration associated with diarrhea (scours) in calves.* * *
(3) The product should not be used in animals with severe dehydration (down, comatose, or in a state of shock). Such animals need intravenous therapy. A veterinarian should be consulted in severely scouring calves. The product is not nutritionally complete if administered by itself for long periods of time. It should not be administered beyond the recommended treatment period without the addition of milk or milk replacer.
3. In § 520.905a, revise paragraphs (e)(2)(i), (e)(2)(iii), (e)(3)(i), and (e)(3)(iii) to read as follows:
(e) * * *
(2) * * *
(i) Amount. Administer orally 5 mg/kg of body weight (2.3 mg/lb). Retreatment may be needed after 4 to 6 weeks.
(iii) Limitations. Cattle must not be slaughtered within 8 days following last treatment. A withdrawal period has not ( printed page 17337) been established for this product in preruminating calves. Do not use in calves to be processed for veal.
(3) * * *
(i) Amount. Administer orally 10 mg/kg of body weight (2.3 mg/lb). Retreatment may be needed after 4 to 6 weeks.
(iii) Limitations. Cattle must not be slaughtered within 8 days following last treatment. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
4. In § 520.905c, revise paragraph (e)(2)(iii) to read as follows:
(e) * * *
(2) * * *
(iii) Limitations. Cattle must not be slaughtered within 8 days following last treatment. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.
5. In § 520.1422, revise paragraph (b) to read as follows:
(b) Sponsor. See No. 053501 in § 510.600(c) of this chapter.
6. In § 520.2043, revise paragraph (d)(1)(iii) to read as follows:
(d) * * *
(1) * * *
(iii) Limitations. Do not use in horses intended for human consumption. When the drug is for administration by stomach tube, it shall be labeled: “Federal law restricts this drug to use by or on the order of a licensed veterinarian.”
7. In § 520.2044, revise paragraph (d)(2) to read as follows:
(d) * * *
(2) Limitations. Do not use in horses intended for human consumption.
8. In § 520.2220a, revise paragraph (d)(3)(ii) to read as follows:
(d) * * *
(3) * * *
(ii) Indications for use. For the treatment of shipping fever complex and bacterial pneumonia associated with Pasteurella spp. sensitive to sulfadimethoxine; and calf diphtheria and foot rot associated with Fusobacterium necrophorum ( Sphaerophorus necrophorus) sensitive to sulfadimethoxine.
9. In § 520.2220b, revise paragraph (d) to read as follows:
(d) Conditions of use —(1) Cattle —(i) Amount. Administer 2.5 grams per 100 pounds body weight for 1 day followed by 1.25 grams per 100 pounds body weight per day; treat for 4 to 5 days.
(ii) Indications for use. For the treatment of shipping fever complex and bacterial pneumonia associated with Pasteurella spp. sensitive to sulfadimethoxine; and calf diphtheria and foot rot associated with Fusobacterium necrophorum sensitive to sulfadimethoxine.
(iii) Limitations. Do not administer within 7 days of slaughter; milk that has been taken from animals during treatment and 60 hours (5 milkings) after the latest treatment must not be used for food. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.
(2) Dogs and cats —(i) Amount. Administer 25 milligrams per pound of body weight on the first day followed by 12.5 milligrams per pound of body weight per day until the animal is free of symptoms for 48 hours.
(ii) Indications for use. Treatment of sulfadimethoxine-susceptible bacterial infections.
(iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
(3) Beef cattle and nonlactating dairy cattle —(i) Amount. Administer one 12.5-gram-sustained-release bolus for the nearest 200 pounds of body weight, i.e., 62.5 milligrams per pound of body weight. Do not repeat treatment for 7 days.
(ii) Indications for use. Treatment of shipping fever complex and bacterial pneumonia associated with organisms such as Pasteurella spp. sensitive to sulfadimethoxine; calf diphtheria and foot rot associated with Fusobacterium necrophorum sensitive to sulfadimethoxine.
(iii) Limitations. Do not use in female dairy cattle 20 months of age or older. Do not administer within 12 days of slaughter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
10. In § 520.2260a, revise paragraph (a)(3)(iii) to read as follows:
(a) * * *
(3) * * *
(iii) Limitations. Administer daily until animal's temperature and appearance are normal. If symptoms persist after using for 2 or 3 days consult a veterinarian. Fluid intake must be adequate. Treatment should continue 24 to 48 hours beyond the remission of disease symptoms, but not to exceed 5 consecutive days. Follow dosages carefully. Do not treat cattle within 10 days of slaughter. Do not use in female dairy cattle 20 months of age or older. Use of sulfamethazine in this class of cattle may cause milk residues. A withdrawal period has not been established in preruminating calves. Do not use in calves to be processed for veal. Do not use in horses intended for human consumption.
11. In § 520.2261a, revise the section heading; the first sentence in paragraph (c)(2)(iii); and paragraph (c)(3) to read as follows:
(c) * * *
(2) * * *
(iii) Chickens and turkeys. In chickens for control of infectious coryza ( Avibacterium paragallinarum), coccidiosis ( Eimeria tenella, Eimeria necatrix), acute fowl cholera ( Pasteurella multocida), and pullorum disease ( Salmonella pullorum). * * *
(3) Limitations. Add the required dose to that amount of water that will be consumed in 1 day. Consumption should be carefully checked. Have only medicated water available during treatment. Withdraw medication from cattle, chickens, and turkeys 10 days prior to slaughter for food. Withdraw medication from swine 15 days before slaughter for food. Do not medicate chickens or turkeys producing eggs for human consumption. Treatment of all diseases should be instituted early. Treatment should continue 24 to 48 hours beyond the remission of disease symptoms, but not to exceed a total of 5 consecutive days in cattle or swine. Medicated cattle, swine, chickens, and turkeys must actually consume enough medicated water which provides the recommended dosages. Do not use in female dairy cattle 20 months of age or ( printed page 17338) older. Use of sulfamethazine in this class of cattle may cause milk residues. A withdrawal period has not been established in preruminating calves. Do not use in calves to be processed for veal.
12. In § 520.2261b, revise paragraph (d)(1)(ii) and paragraph (d)(4)(iii) to read as follows:
(d) * * *
(1) * * *
(ii) Indications for use. For control of infectious coryza ( Avibacterium paragallinarum), coccidiosis ( Eimeria tenella, E. necatrix), acute fowl cholera ( Pasteurella multocida), and pullorum disease ( Salmonella pullorum).
(4) * * *
(iii) Limitations. Add the required dose to that amount of water that will be consumed in 1 day. Consumption should be carefully checked. Have only medicated water available during treatment. Withdraw medication from cattle 10 days prior to slaughter for food. Treatment of all diseases should be instituted early. Treatment should continue 24 to 48 hours beyond the remission of disease symptoms, but not to exceed a total of 5 consecutive days. Medicated cattle must actually consume enough medicated water which provides the recommended dosages. Do not use in female dairy cattle 20 months of age or older. Use of sulfamethazine in this class of cattle may cause milk residues. A withdrawal period has not been established in preruminating calves. Do not use in calves to be processed for veal.
13. In § 520.2345d, revise paragraph (b)(2), the first sentence in paragraph (d)(1)(iii), and paragraph (d)(2)(iii) to read as follows:
(b) * * *
(2) No. 000010: 25, 102.4, and 324 grams per pound as in paragraph (d) of this section.
(d) * * *
(1) * * *
(iii) Limitations. Administer for 3 to 5 days; do not slaughter animals for food within 4 days of treatment for No. 000010 and within 5 days of treatment for Nos. 046573, 054925, 057561, 059130, and 061623; prepare a fresh solution daily; use as the sole source of tetracycline. * * *
(2) * * *
(iii) Limitations. Administer for 3 to 5 days; do not slaughter animals for food within 7 days of treatment for No. 000010 and within 4 days of treatment for Nos. 046573, 054925, 057561, 059130, and 061623; prepare a fresh solution daily; use as the sole source of tetracycline.
14. The authority citation for 21 CFR part 522 continues to read as follows:
15. Revise § 522.56 to read as follows:
(a) Specifications. Each milliliter of solution contains 50 milligrams (mg) of amikacin as amikacin sulfate.
(b) Sponsors. See Nos. 000856 and 059130 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs —(1) Amount. 5 mg/pound (lb) of body weight twice daily by intramuscular or subcutaneous injection.
(2) Indications for use. For treatment of genitourinary tract infections (cystitis) caused by susceptible strains of Escherichia coli and Proteus spp. and skin and soft tissue infections caused by susceptible strains of Pseudomonas spp. and E. coli.
(3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
16. In § 522.90b, revise the section heading and paragraphs (a), (b), and (d) to read as follows:
(a) Specifications. Each milliliter of aqueous suspension constituted from ampicillin trihydrate powder contains 50, 100, or 250 milligrams (mg) ampicillin equivalents.
(b) Sponsors. See Nos. 000010 and 010515 in § 510.600(c) of this chapter.
(d) Conditions of use —(1) Dogs and cats —(i) Amount. 3 mg/pound (lb) of body weight twice daily by subcutaneous or intramuscular injection.
(ii) Indications for use. For treatment of strains of organisms susceptible to ampicillin and associated with respiratory tract infections, urinary tract infections, gastrointestinal infections, skin infections, soft tissue infections, and postsurgical infections.
(iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
(2) Cattle —(i) Amount. 2 to 5 mg/lb of body weight once daily by intramuscular injection.
(ii) Indications for use. For treatment of respiratory tract infections caused by organisms susceptible to ampicillin, bacterial pneumonia (shipping fever, calf pneumonia, and bovine pneumonia) caused by Aerobacter spp., Klebsiella spp., Staphylococcus spp., Streptococcus spp., Pasteurella multocida, and Escherichia coli.
(iii) Limitations. Do not treat cattle for more than 7 days. Milk from treated cows must not be used for food during treatment or for 48 hours (4 milkings) after the last treatment. Cattle must not be slaughtered for food during treatment or for 144 hours (6 days) after the last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
17. In § 522.313b, revise paragraph (a) to read as follows:
(a) Specifications. Each milliliter of ceftiofur hydrochloride suspension contains 50 milligrams (mg) ceftiofur equivalents.
18. In § 522.1010, redesignate paragraph (d)(3)(iii) as paragraph (d)(2)(iii); and add new paragraph (d)(3)(iii) to read as follows:
(d) * * *
(3) * * *
(iii) Limitations. Treatment not to exceed 48 hours post-parturition. Milk taken during treatment and for 48 hours (four milkings) after the last treatment must not be used for food. Cattle must not be slaughtered for food within 48 hours following last treatment.
19. The authority citation for 21 CFR part 526 continues to read as follows:
20. In § 526.363, revise paragraph (d)(1) and the first sentence in paragraph (d)(3) to read as follows:
(d) * * *
(1) Amount. Infuse the contents of one syringe into each quarter.
(3) Limitations. Infuse each quarter following last milking, but no later than 30 days before calving. * * *
21. The authority citation for 21 CFR part 529 continues to read as follows:
22. Redesignate § 529.50 as § 529.56 and revise it to read as follows:
(a) Specifications. Each milliliter (mL) of solution contains 250 milligrams of amikacin as amikacin sulfate.
(b) Sponsors. See Nos. 000856 and 059130 in § 510.600(c) of this chapter.
(c) Conditions of use in horses —(1) Amount. Administer 2 grams (8 mL) diluted with 200 mL of sterile physiological saline by intrauterine infusion daily for 3 consecutive days.
(2) Indications for use. For treating genital tract infections (endometritis, metritis, and pyometra) in mares caused by susceptible organisms including Escherichia coli, Pseudomonas spp., and Klebsiella spp.
(3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
23. In § 529.1030, revise paragraphs (d)(1)(i) and (d)(1)(iv) to read as follows:
(d) * * *
(1) * * *
(i) Select finfish. For control of external protozoa Ichthyophthirius spp., Chilodonella spp., Ichthyobodo spp., Ambiphrya spp., Epistylis spp., and Trichodina spp., and monogenetic trematodes Cleidodiscus spp., Gyrodactylus spp., and Dactylogyrus spp., on salmon, trout, catfish, largemouth bass, and bluegill.
(iv) All finfish. For control of external protozoa Ichthyophthirius spp., Chilodonella spp., Ichthyobodo spp., Ambiphrya spp., Epistylis spp., and Trichodina spp., and monogenetic trematodes Cleidodiscus spp., Gyrodactylus spp., and Dactylogyrus spp.
Dated: March 23, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-7313 Filed 3-28-11; 8:45 am]
BILLING CODE 4160-01-P